Harbin Medisan Pharmaceutical Co., Ltd. (SHE:002900)
China flag China · Delayed Price · Currency is CNY
12.22
-0.04 (-0.33%)
Feb 27, 2026, 3:04 PM CST

SHE:002900 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
3,7833,0494,2284,2296,4532,866
Market Cap Growth
27.96%-27.88%-0.01%-34.47%125.19%-22.59%
Enterprise Value
4,0903,1263,8153,6756,0092,152
Last Close Price
12.229.7113.1913.0919.478.62
PE Ratio
-51.9757.40139.9918.3997.72
Forward PE
-40.2640.2640.2640.2640.26
PS Ratio
4.322.693.564.116.822.14
PB Ratio
1.991.411.972.063.051.60
P/TBV Ratio
2.131.492.092.143.181.69
P/FCF Ratio
---76.30--
P/OCF Ratio
36.5699.37118.4529.24--
EV/Sales Ratio
4.682.763.223.576.351.61
EV/EBITDA Ratio
-23.4742.1956.52-32.78
EV/EBIT Ratio
-95.56----
EV/FCF Ratio
-31.06--66.31--
Debt / Equity Ratio
0.550.430.330.320.230.15
Debt / EBITDA Ratio
-6.517.138.80-4.11
Debt / FCF Ratio
---11.85--
Net Debt / Equity Ratio
0.160.04-0.15-0.31-0.29-0.42
Net Debt / EBITDA Ratio
-5.600.70-3.65-9.8010.36-11.46
Net Debt / FCF Ratio
-2.32-0.301.25-11.507.215.00
Asset Turnover
0.240.310.350.320.340.52
Inventory Turnover
1.912.152.572.271.822.43
Quick Ratio
0.690.861.362.382.322.01
Current Ratio
0.971.171.702.722.662.45
Return on Equity (ROE)
-9.58%2.55%3.34%1.27%17.89%1.46%
Return on Assets (ROA)
-2.73%0.56%-0.15%-0.63%-3.38%-0.35%
Return on Invested Capital (ROIC)
-7.01%1.47%-0.43%-1.45%-9.15%-1.22%
Return on Capital Employed (ROCE)
-6.60%1.30%-0.30%-1.20%-5.90%-0.80%
Earnings Yield
-5.04%1.92%1.74%0.71%5.44%1.02%
FCF Yield
-3.48%-10.35%-6.24%1.31%-1.34%-5.25%
Dividend Yield
1.64%2.06%1.52%0.76%1.64%0.93%
Payout Ratio
-178.20%55.71%361.96%9.78%326.66%
Buyback Yield / Dilution
-2.72%-0.61%-1.61%2.74%4.68%-4.82%
Total Shareholder Return
-1.10%1.44%-0.09%3.50%6.33%-3.89%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.